DXCM R&D to Revenue

Dexcom · R&D to Revenue

DXCM logo

DXCM R&D to Revenue

Latest reported12.85%
DXCM FY R&D/Revenue (0.00% → 12.85%)
High-resolution chart · PNG

DXCM r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
12.8507%
13.697%
13.9635%
16.6403%
24.6763%
18.6796%
18.5298%
40.4614%
25.8038%
27.2283%
34.204%
26.7747%
28%
39.5395%
40.3155%
47.7617%
48.1393%
199.5223%
348.6276%
894.9968%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.